Telehealth AUD
Telehealth for alcohol use disorder provides remote medical evaluation, prescription medications like naltrexone, and behavioral support—all confidential and accessible from home. Clero Health is building an evidence-based AUD care platform designed to eliminate in-person visits and reduce barriers to treatment.
Say "alcohol treatment" and most people picture the residential version: a month away, group sessions, folding chairs. Telehealth for alcohol use disorder looks nothing like that. It is ordinary outpatient medicine — a health questionnaire, a licensed clinician, FDA-approved medication when it fits, scheduled follow-up — delivered through a video or phone visit instead of across a desk. NIAAA's overview of telehealth options for alcohol sorts the field into three lanes: professional care by phone or video, self-guided online programs, and online mutual-support groups. The lane with the most moving parts is the first one, and three questions decide whether it fits: how the care actually works, what a screen cannot do, and what happens to your information.
The gap it exists to close
In 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder — about 9.7% of that age group, per NIAAA.
In the same year, NIAAA's treatment figures show about 2.1 million of those people — roughly 7.6% — received any alcohol-use treatment at all.
Some of that gap is stigma: not wanting to be seen walking into a clinic. Some is logistics — distance, waiting lists, jobs that do not pause for a weekly appointment. Remote care was built against exactly those barriers. The medicine is the same as an office visit's; what changes is how much a person has to rearrange, and reveal, to reach it.
What a remote visit actually involves
The pathway runs close to in-person outpatient care. You start with an intake questionnaire covering drinking pattern, medical history, current medications, mental health, past withdrawal symptoms, and your goal — and "cut back" is a legitimate goal to name, not only "stop entirely." A licensed clinician reviews the intake in a video or phone appointment, asks follow-up questions, and works out a plan with you. Licensing is location-bound — the clinician must hold a license in the state where you are, which is why services ask for your location before anything else. If medication is part of the plan, the prescription goes to a regular pharmacy or a mail-order one, and follow-up happens on a schedule: more video visits, secure messaging, sometimes lab work ordered at a lab near you. For a broader map of what online alcohol care can include beyond the medical visit, see telehealth alcohol treatment.
Three medications, three different jobs
The medication conversation draws on the same three FDA-approved options an office-based clinician would consider, and as one peer-reviewed overview of alcohol-dependence medications lays out, they do genuinely different jobs.
Naltrexone blocks opioid receptors — the reward circuitry alcohol leans on for its pleasant lift — so a drink delivers less of what made it compelling. Its FDA label on DailyMed lists it as indicated for the treatment of alcohol dependence as part of a broader plan, not as a standalone fix, and it does not mix with opioid painkillers — one reason the intake asks about every medication you take.
Acamprosate works at the other end of the process. Years of heavy drinking reset the balance between the brain's "go" and "calm" signals; stop drinking and that tilt lingers, which is part of why early sobriety can feel so restless. Acamprosate is thought to help that balance settle back, which is why it is used to help people who have already quit stay stopped.
Disulfiram is the tripwire. It blocks the enzyme that breaks down acetaldehyde, a toxic byproduct of alcohol, so drinking while taking it brings on flushing, nausea, and a pounding heart. It suits people who want a hard deterrent, and it works only for as long as it is taken.
One legal detail explains why all three can be prescribed remotely: federal telehealth rules restrict remote prescribing of controlled substances, and none of these medications is one. A clinician who has evaluated you by video can prescribe them the way any office-based clinician can.
What a screen cannot do
A video visit includes no physical exam and no same-room testing. Anything a clinician needs to touch, listen to, or measure has to happen locally.
The harder limit is withdrawal. Someone drinking heavily every day can be in real danger stopping abruptly — shaking, sweating, confusion, hallucinations, seizures — and that risk needs in-person medical supervision, not a video appointment. A responsible service screens for it at intake and refers out rather than proceeding. If those symptoms are happening now, call 911 or go to an emergency room; this is the one part of alcohol care where physical presence genuinely matters. There is more background in understanding alcohol withdrawal. And thoughts of self-harm belong with the 988 Suicide & Crisis Lifeline, not an intake queue.
What happens to your information
For many people the entire appeal of remote care is that nobody sees them walk in anywhere. The legal protection behind that is real, with edges worth knowing. The HIPAA Privacy Rule sets federal limits on how clinicians and health platforms use and disclose health information, and substance-use treatment records carry an additional layer of federal confidentiality protection (42 CFR Part 2, summarized by SAMHSA) that generally requires your written consent before those records are shared.
Law is not the whole picture. In 2024 the FTC settled charges against an alcohol telehealth company that had shared users' health information with advertising platforms; the settlement banned it from disclosing health data for ads. Privacy depends on a company's practices as much as on the statute. Before enrolling anywhere, check whether the service requires a social-media login, what its privacy policy says about advertising and analytics tools, and — if medication ships — what the packaging looks like.
Online or in person
The obvious next question — is remote care as good as showing up somewhere? — has an unglamorous answer: it is the same medicine aimed at different situations. Telehealth removes the commute, the waiting room, and the visibility, which matters most when exposure or logistics is the main barrier. In-person care offers what remote care structurally cannot: physical exams, supervised withdrawal management, intensive outpatient programs, residential structure. Someone medically stable who wants medication support and steady follow-up loses little by choosing a screen. Someone with a history of severe withdrawal, unstable health, or a need for daily structure gains a lot by choosing a building. Neither is the "serious" option. They are matched to different levels of medical risk.
Before you sign up anywhere
Three things you can do without committing to any service:
- Write the honest version of the pattern down first. How much, how often, what you want to change. Intake forms are easier to answer truthfully once you have told yourself the truth, and a clinician's safety judgment is only as good as the picture you give them.
- Bring the same three questions to every service you consider. Is the person evaluating me a licensed clinician in my state? What does follow-up look like after the first visit? And what happens if I turn out to need in-person care — is there a referral, or does the service just stop being useful?
- If withdrawal has ever been part of your story, start in person. Shaking, sweating, or worse when you stop is the one history item that changes which doorway is right.
If the missing piece is simply a clinician to put the question to, that specific gap is what Clero is built around: a telehealth visit with a licensed clinician who can look at your history and talk through whether a medication like naltrexone fits the goal you actually have.
Most of the distance between 27.9 million people with alcohol use disorder and the 2.1 million treated comes down to doorways rather than medicine. Telehealth adds one more doorway. Judge it the way you would judge any other — by who is standing on the other side of it.
FAQ
Do I have to want to quit entirely?
No. Reducing drinking is a goal a clinician can work with, and it is worth naming plainly at intake, because the goal shapes which medication, if any, makes sense to discuss — a stay-stopped medicine and a drink-less medicine are different conversations.
How do I know whether my drinking even counts as alcohol use disorder?
That is a clinician's call, made against a defined pattern of symptoms over the past year — not a moral category you assign yourself. What is alcohol use disorder walks through the criteria in plain language. If you are asking the question seriously, it is worth a real evaluation rather than a late-night quiz.
This article is general education, not medical advice or an endorsement of any service; medication decisions belong with a licensed clinician who knows your history. If stopping drinking has ever brought shaking, confusion, hallucinations, or a seizure, treat withdrawal as a medical event — call 911 or go to an emergency room. For self-harm thoughts, call or text 988; for confidential treatment referrals, SAMHSA's helpline is 1-800-662-HELP (4357).
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.